Clinical Trial Update: A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A) [Phase 3]

View source ↗

Summary

Phase 3 study of atezolizumab in participants previously enrolled in Roche-sponsored trials is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING